Events

Search Language

English | Use language selector above (below, on mobile) to search additional languages

323 items matching filters

Search Results

Events

Too QM or Not‐2‐QM

Steve vonBerg joined a panel to discuss what mortgage executives are thinking, issues they are working through, and best practices for navigating 2023.

Events

2022 P3 Government Conference

Energy & Infrastructure partner Matthew Neuringer moderated a panel on Thursday, December 1, on “IIJA and Transportation: What Have We Learned One Year Later?” during the 2022 P3 Government Conference. The panel covered the impact of the Infrastructure Investment and Jobs Act (IIJA) on ...

Events

2022 TechGC Global Summit

Thora Johnson will be leading a breakout topic session at the 2022 TechGC Global Summit.

Events

Post-Issuance Compliance Workshop

JOIN BLX AND ORRICK AT THE POST-ISSUANCE COMPLIANCE WORKSHOP A Comprehensive Overview of Post-Issuance Tax Law and SEC Secondary Market Disclosure for 501(c)(3) Organizations and State and Local Government Issuers Who Utilize Tax-Exempt Financing Virgin Hotels Nashville and Virtual - November 3-4, ...

Events

Privacy + Security Forum Fall Academy

Members of Orrick’s Cyber, Privacy & Data Innovation Group are leading panels on privacy for children and teens in the United States (U.S.) and online safety in the United Kingdom (UK) during the Privacy + Security Forum Fall Academy hosted by the Privacy + Security Academy. The Privacy + Security ...

Events

International Bar Association Annual Conference 2022

James Parkinson drew upon his compliance and enforcement experience to discuss key anti-corruption developments from the past 12 months, and their impact on the legal and enforcement landscape.

Events

Are there still opportunities in China and Asia for US biopharmas?

China is the second largest pharmaceutical market in the world, growing to $205bn by 2026. With an increasing focus on innovation and early access, many US biopharmas have found that an anchor in China supports accelerated clinical development and creates incremental value via either through equity ...